Zen Oncology plans bulk drug unit at Bavvla

Details

Category: Bulk Drug Manufacturing

Zen Oncology Pvt Ltd plans bulk drug and intermediates unit at Bavvla Taluka in Ahmedabad district of Gujarat with an investment of Rs. 620 million. The company plans to manufacture Carboplatin (0.3 mtpm), Oxaliplatin (0.3 mtpm), Paclitaxel (0.3 mtpm), Docetaxel (0.3 mtpm), Irinotecan Hydrochloride (0.3 mtpm) and Gemcitabine Hydrochloride (1.5 mtpm). The total production capacity of the unit will be around 3 mtpm.

• < Prev
• Next >